Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Tumescent Lidocaine Maximum Safe mg/kg Dosage (TLA)

This study is enrolling participants by invitation only.
Sponsor:
Information provided by:
Klein, Jeffrey A., M.D.
ClinicalTrials.gov Identifier:
NCT00977028
First received: September 12, 2009
Last updated: June 14, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: August 2011
  Estimated Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)